Group | UA | 40-64 years | Over 65 years | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Incidence case | Crude | Adjusteda) | Incidence case | Crude | Adjusteda) | ||||||
HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | ||||
Male | T1 | 23 (8.0) | 1.00 (Reference) | 1.00 (Reference) | 32 (11.6) | 1.00 (Reference) | 1.00 (Reference) | ||||
T2 | 30 (9.4) | 1.17 (0.68–2.02) | 0.56 | 0.95 (0.49–1.85) | 0.88 | 34 (14.7) | 1.27 (0.79–2.06) | 0.33 | 1.14 (0.63–2.07) | 0.66 | |
T3 | 50 (13.9) | 1.74 (1.06–2.85) | <0.05 | 1.74 (0.92–3.28) | 0.09 | 50 (19.2) | 1.66 (1.07–2.59) | 0.02 | 1.51 (0.87–2.63) | 0.14 | |
Female | T1 | 41 (7.1) | 1.00 (Reference) | 1.00 (Reference) | 52 (17.6) | 1.00 (Reference) | 1.00 (Reference) | ||||
T2 | 72 (9.9) | 1.40 (0.95–2.05) | <0.05 | 1.22 (0.78–1.93) | 0.38 | 43 (15.8) | 0.89 (0.60–1.34) | 0.59 | 0.91 (0.59–1.42) | 0.68 | |
T3 | 88 (13.4) | 1.88 (1.30–2.72) | <0.05 | 1.59 (1.01–2.50) | <0.05 | 64 (19.4) | 1.10 (0.76–1.59) | 0.61 | 0.94 (0.60–1.46) | 0.77 |